Cr. Boschman et al., EXPRESSION OF P53 PROTEIN IN PRECURSOR LESIONS AND ADENOCARCINOMA OF HUMAN PANCREAS, The American journal of pathology, 145(6), 1994, pp. 1291-1295
To evaluate the incidence and stage at which p53 alterations occur in
human pancreatic carcinogenesis, we examined primary and metastatic ca
rcinomas, carcinoma in situ, and hyperplastic lesions with and without
atypia for p53 protein overexpression by immunohistochemical procedur
e. Overexpression of p53 was observed in 40% (10/25) of primary tumors
, 29% (2/7) of metastatic tumors, 36% (5/14) of carcinoma in situ, and
35% (6/17) of hyperplastic lesions. These results suggest that p53 pr
otein overexpression is not only a common genetic alteration but also
occurs very early the development of these tumors. It is suggested tha
t p53 overexpression can be used as a marker to identify precursor les
ions that have increased potential to develop into malignant tumors.